Trotana Therapeutics

San Diego, United States

Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.

$52.5M raised

Feb 2025

Series A

Biotechnology Pharmaceutical Therapeutics

Top Investors

Lightstone Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trotana Therapeutics

How much funding has Trotana Therapeutics raised?

Trotana Therapeutics has raised $52.5M in total funding. The most recent round was Series A. The last funding was announced in February 2025.

Who are Trotana Therapeutics's investors?

Trotana Therapeutics's investors include Lightstone Ventures.

Where is Trotana Therapeutics headquartered?

Trotana Therapeutics is headquartered in San Diego, United States.

What does Trotana Therapeutics do?

Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.

What stage is Trotana Therapeutics at?

Trotana Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2025.

MLA

"Trotana Therapeutics — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/trotana-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Trotana Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/trotana-therapeutics

Wikipedia (cite web)

{{cite web |title=Trotana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trotana-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2025.